Patent · US Active

Heterocyclic compounds and uses thereof

US9775844B2 · kind B2 · utility

11Cited by

247References

48Claims

0Family size

Assignee

Infinity Pharmaceuticals, Inc. · US

Inventors

Jeffery L. Kutok · Natick, US
David G. Winkler · Arlington, US
Vito J. Palombella · Needham, US
Alfredo C. Castro · Woburn, US
Catherine A. Evans · Somerville, US
Somarajannair Janardanannair · Woburn, US
Andre Lescarbeau · Somerville, US
Tao Liu · Shanghai, CN
Martin Tremblay · Waltham, US

Key dates

Filing date	Mar 18, 2015
Grant date	Oct 3, 2017
Priority date	—
Expiry date	Mar 18, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.